by Doug Pearson | Oct 31, 2018 | Pharmaceutical, PTAB News, PTAB Trial Basics
By Doug Pearson Prior to the USPTO’s issuance of revised Standard Operating Procedure (SOP) 2 on September 20, 2018 (available here), designation of Board decisions as Precedential or Informative required, among other things, nomination of a decision to the Chief...
by Matthew Johnson | Oct 30, 2018 | Pharmaceutical, PTAB News, PTAB Trial Basics
By Josh Nightingale and Matt Johnson The USPTO has revised its standard operating procedure (SOP) governing the assignment of judges to panels in Patent Trial and Appeal Board (PTAB) cases. The SOP, available here, provides guidance to Board administrative personnel...
by Joe Sauer | Oct 24, 2018 | PTAB News
By David Anderson and Joe Sauer As an update to the May 15, 2018 post, available here, some post-SAS trends appear to be taking shape. For the five-month period from May 2018 through September 2018, the PTAB issued 538 institution decisions. Of these, the PTAB...
by S. Christian Platt | Sep 19, 2018 | PTAB News
By: Amanda Leckman and S. Christian Platt Patent Trial and Appeal Board (“PTAB”) hearings are typically open to the public, and a schedule of upcoming hearings is posted on the United States Patent and Trademark Office (“USPTO”) website. But hearings are only...
by Matthew Johnson | Aug 14, 2018 | Amendment Practice, PTAB News
By: Matt Johnson On Monday, the PTAB issued its fourth installment of its ongoing motion to amend study, providing details on motions to amend filed and decided through March 31, 2018. Patent owners have filed a motion to amend in 305 of the 3,203 completed trials...
by Matthew Johnson | Aug 10, 2018 | PTAB News, Uncategorized
By: Rich Graham and Matt Johnson The USPTO’s Patent Trial and Appeal Board (PTAB) has published an update to the AIA Trial Practice Guide (TPG) containing additional guidance about trial practice before the Board. The USPTO published the original TPG in August...
